Esperion Therapeutics (ESPR) Q3 2025 Earnings

5AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.21
-0.15
-0.08
-0.02

Details

Expected EPS
-0.145714
Actual EPS
-0.02
Surprise EPS
0.13
Surprise Percent
+86.27%

Description

Esperion Therapeutics (ESPR) has reported earnings of -0.02 per share for Q3 2025.

0 Comments

Share your thoughts